Literature DB >> 17981661

Steroids and nitric oxide in sepsis.

Daniel Fernandes1, Danielle Duma, Jamil Assreuy.   

Abstract

Nitric oxide (NO) is produced by several cell types and has effects both detrimental and beneficial to the host. Sepsis and septic shock are conditions in which NO plays a central role in physiopathology. Stressful circumstances such as pathogens, toxins, and trauma elicit a wide variety of physiological changes. Steroid hormones and notably glucocorticoids are one of the main players in this orchestrated response. Although steroids have been used for sepsis some decades ago, their use in this condition was practically banned for several years following studies showing that high glucocorticoid doses were harmful to the host. Recently, the subject has been raised again since some studies demonstrated that adrenal insufficiency may happen in sepsis and that low dose/long-term regimen with cortisol may be beneficial to sepsis and septic shock. However, there are great gaps in our knowledge regarding the role played by steroids in sepsis, as well as the contribution of NO. In the present review, we will attempt to highlight the relationship among NO, sepsis and steroids, mainly glucocorticoids. A second purpose is to raise some unanswered questions that may provide better therapeutic alternatives to treat sepsis and septic shock.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981661     DOI: 10.2741/2793

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  2 in total

1.  Disturbances of the hypothalamic-pituitary-adrenal axis and plasma electrolytes during experimental sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Sebastian Weckbach; Markus Huber-Lang; Kyros Ipaktchi; Peter A Ward; Philip F Stahel
Journal:  Ann Intensive Care       Date:  2011-12-30       Impact factor: 6.925

2.  In vivo Angiotensin II AT1 receptor blockade selectively inhibits LPS-induced innate immune response and ACTH release in rat pituitary gland.

Authors:  Enrique Sánchez-Lemus; Julius Benicky; Jaroslav Pavel; Juan M Saavedra
Journal:  Brain Behav Immun       Date:  2009-05-07       Impact factor: 7.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.